New and known type 2 diabetes as coronary heart disease equivalent: Results from 7.6 year follow up in a middle east population

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Hadaegh, Farzad ^a   Fahimfar, Nooshin ^a   Khalili, Davood ^a,b   Sheikholeslami, Farhad ^a   Azizi, Fereidoun ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; LIPID;

ADULT; ARTICLE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; SELF REPORT; ASIAN; BLOOD; CHI SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; ETHNOLOGY; FOLLOW UP; IRAN; METABOLISM; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STATISTICS; TIME;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; LIPIDS; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS;

EID: 78649569847     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-84     Document Type: Article

References (35)

1. Howard BV, Best LG, Galloway JM, Howard WJ, Jones K, Lee ET, Ratner RE, Resnick HE, Devereux RB. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006, 29:391-397. 10.2337/diacare.29.02.06.dc05-1299, 16443893.
2. Juutilainen A, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Type 2 diabetes as a "coronary heart disease equivalent": an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005, 28:2901-2907. 10.2337/diacare.28.12.2901, 16306552.
3. Whiteley L, Padmanabhan S, Hole D, Isles C. Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey. Diabetes Care 2005, 28:1588-1593. 10.2337/diacare.28.7.1588, 15983305.
4. Gruppetta M, Calleja N, Fava S. Long-term survival after acute myocardial infarction and relation to type 2 diabetes and other risk factors. Clin Cardiol 33:424-429. 10.1002/clc.20776, 20641120.
5. Standards of medical care in diabetes--2009. Diabetes Care 2009, 32(Suppl 1):S13-61. 2613589, 19118286.
6. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002, 40:954-960. 10.1016/S0735-1097(02)02044-2, 12225722.
7. Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002, 324:939-942. 10.1136/bmj.324.7343.939, 102325, 11964337.
8. Vaccaro O, Eberly LE, Neaton JD, Yang L, Riccardi G, Stamler J. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial. Arch Intern Med 2004, 164:1438-1443. 10.1001/archinte.164.13.1438, 15249353.
9. Becker A, Bos G, de Vegt F, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease. 10-year follow-up of the Hoorn Study. Eur Heart J 2003, 24:1406-1413. 10.1016/S0195-668X(03)00197-0, 12909069.
10. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993, 16:434-444. 10.2337/diacare.16.2.434, 8432214.
11. Nijjar AP, Wang H, Dasgupta K, Rabi DM, Quan H, Khan NA. Outcomes in a diabetic population of South Asians and whites following hospitalization for acute myocardial infarction: a retrospective cohort study. Cardiovasc Diabetol 2010, 9:4. 10.1186/1475-2840-9-4, 2816974, 20096107.
12. Diabetes Atlas. 2006, Brussels: International Diabetes Federation.
13. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world--a growing challenge. N Engl J Med 2007, 356:213-215. 10.1056/NEJMp068177, 17229948.
14. Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health 2008, 8:176. 10.1186/1471-2458-8-176, 2413226, 18501007.
15. Harati H, Hadaegh F, Saadat N, Azizi F. Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health 2009, 9:186. 10.1186/1471-2458-9-186, 2708154, 19531260.
16. Ghassemi H, Harrison G, Mohammad K. An accelerated nutrition transition in Iran. Public Health Nutr 2002, 5:149-155. 10.1079/PHN2001287, 12027278.
17. Baynouna LM, Revel AD, Nagelkerke NJ, Jaber TM, Omar AO, Ahmed NM, Nazirudeen MK, Al Sayed MF, Nour FA, Abdouni S. Associations of cardiovascular risk factors in Al Ain, United Arab Emirates. Cardiovasc Diabetol 2009, 8:21. 10.1186/1475-2840-8-21, 2673216, 19371412.
18. Hadaegh F, Harati H, Ghanbarian A, Azizi F. Prevalence of coronary heart disease among Tehran adults: Tehran Lipid and Glucose Study. East Mediterr Health J 2009, 15:157-166.
19. Hadaegh F, Khalili D, Fahimfar N, Tohidi M, Eskandari F, Azizi F. Glucose intolerance and risk of cardiovascular disease in Iranian men and women: results of the 7.6-year follow-up of the Tehran Lipid and Glucose Study (TLGS). J Endocrinol Invest 2009, 32:724-730.
20. Azizi F, Ghanbarian A, Momenan AA, Hadaegh F, Mirmiran P, Hedayati M, Mehrabi Y, Zahedi-Asl S. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 2009, 10:5. 2656492, 19166627.
21. prineas R, Blackburn H. The minnesota code mannual of electrocardiographic findings: standards and procedures for measurement and classification. 1982, Boston: Wright-PSG.
22. Ford ES, Giles WH, Croft JB. Prevalence of nonfatal coronary heart disease among American adults. Am Heart J 2000, 139:371-377. 10.1016/S0002-8703(00)90076-0, 10689247.
23. Hadaegh F, Khalili D, Ghasemi A, Tohidi M, Sheikholeslami F, Azizi F. Triglyceride/HDL-cholesterol ratio is an independent predictor for coronary heart disease in a population of Iranian men. Nutr Metab Cardiovasc Dis 2009, 19:401-408. 10.1016/j.numecd.2008.09.003, 19091534.
24. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234. 10.1056/NEJM199807233390404, 9673301.
25. Schramm TK, Gislason GH, Kober L, Rasmussen S, Rasmussen JN, Abildstrom SZ, Hansen ML, Folke F, Buch P, Madsen M, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008, 117:1945-1954. 10.1161/CIRCULATIONAHA.107.720847, 18378618.
26. Lee CD, Folsom AR, Pankow JS, Brancati FL. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004, 109:855-860. 10.1161/01.CIR.0000116389.61864.DE, 14757692.
27. Hu FB, Stampfer MJ, Solomon CG, Liu S, Willett WC, Speizer FE, Nathan DM, Manson JE. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001, 161:1717-1723. 10.1001/archinte.161.14.1717, 11485504.
28. Krempf M, Parhofer KG, Steg PG, Bhatt DL, Ohman EM, Rother J, Goto S, Pasquet B, Wilson PW. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol 2010, 105:667-671. 10.1016/j.amjcard.2009.10.048, 20185014.
29. Gonzalez-Clemente JM, Palma S, Arroyo J, Vilardell C, Caixas A, Gimenez-Palop O, Delgado-Rodriguez M. [Is diabetes mellitus a coronary heart disease equivalent? Results of a meta-analysis of prospective studies]. Rev Esp Cardiol 2007, 60:1167-1176. 10.1157/13111789, 17996177.
30. Eberly LE, Cohen JD, Prineas R, Yang L. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care 2003, 26:848-854. 10.2337/diacare.26.3.848, 12610048.
31. Carnethon MR, Biggs ML, Barzilay J, Kuller LH, Mozaffarian D, Mukamal K, Smith NL, Siscovick D. Diabetes and coronary heart disease as risk factors for mortality in older adults. Am J Med 2010, 123:556-559. e551, 10.1016/j.amjmed.2009.11.023, 20569763.
32. Andersson C, Gislason GH, Weeke P, Hoffmann S, Hansen PR, Torp-Pedersen C, Sogaard P. Diabetes is associated with impaired myocardial performance in patients without significant coronary artery disease. Cardiovasc Diabetol 2010, 9:3. 10.1186/1475-2840-9-3, 2818623, 20082690.
33. Esteghamati A, Abbasi M, Nakhjavani M, Yousefizadeh A, Basa AP, Afshar H. Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome. Cardiovasc Diabetol 2006, 5:15. 10.1186/1475-2840-5-15, 1550715, 16842631.
34. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, et al. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007, 116:151-157. 10.1161/CIRCULATIONAHA.106.685628, 17576864.
35. Dagenais GR, St-Pierre A, Gilbert P, Lamarche B, Despres JP, Bernard PM, Bogaty P. Comparison of prognosis for men with type 2 diabetes mellitus and men with cardiovascular disease. Cmaj 2009, 180:40-47. 2612049, 19124789.